55 Participants Needed

SPECTROM Training for Training Group

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of New Mexico
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the SPECTROM Training treatment?

The research suggests that training programs for dual diagnosis (mental health and substance misuse) have been positively evaluated by participants, indicating potential effectiveness. Additionally, pilot studies of interventions for dual diagnosis treatment have shown positive results, suggesting that similar training programs like SPECTROM could be beneficial.12345

How is SPECTROM Training different from other treatments for dual diagnosis?

SPECTROM Training is unique because it focuses on training healthcare providers in dual diagnosis, which involves both mental health and substance misuse, rather than directly treating patients. This approach aims to improve the skills and confidence of healthcare providers, which can lead to better patient outcomes.13678

What is the purpose of this trial?

This is a clinical trial, with participants undergoing the 16 hour SPECTROM training, and completing 2 assessments before and after training (the Psychotropic Knowledge Questionnaire-Revised and the Management of Aggression and Violence Attitude Scale-Revised-ID).

Eligibility Criteria

This trial is for English-speaking individuals aged 18 or older who work at the 3 ARCA group homes or the UNM psychiatric center. It's designed to help them improve their understanding and management of dual diagnosis conditions.

Exclusion Criteria

All participants must be fluent in English because for this pilot study we do not have funds to translate study materials.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

Participants undergo the 16-hour SPECTROM training and complete assessments

1 week
1 visit (in-person)

Follow-up

Participants are monitored for knowledge retention and behavior management effectiveness

6 months

Treatment Details

Interventions

  • SPECTROM Training
Trial Overview The SPECTROM Training program, which spans over a total of 16 hours, is being tested. Participants will be assessed before and after training using two tools: the Psychotropic Knowledge Questionnaire-Revised and the Management of Aggression and Violence Attitude Scale-Revised-ID.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Training ArmExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of New Mexico

Lead Sponsor

Trials
393
Recruited
3,526,000+

Findings from Research

The dual diagnosis training program, initiated in 2003 across three NHS trusts, aimed to improve the treatment of individuals with both mental health issues and substance misuse, highlighting the importance of integrated care.
The article evaluates the first year of the program, focusing on the training provided and participants' feedback, indicating a commitment to enhancing the skills of healthcare professionals in managing complex cases.
Participants' evaluation of a training programme in dual diagnosis.Cooper, P., Doolin, N., Hemming, I., et al.[2019]
Different treatment models (serial, parallel, and integrated) can help healthcare providers optimize resources for patients with dual diagnoses, but these models need further empirical testing to determine their effectiveness.
Pilot studies have shown positive results for interventions targeting dual diagnosis patients, highlighting the urgent need for well-designed programs to address their unique treatment needs.
Clinical treatment matching models for dually diagnosed patients.Ries, R.[2005]
A systematic review identified only 11 articles on staff training for dual diagnosis competencies from a pool of 129 potential studies, highlighting a significant lack of research in this area.
The existing studies faced issues such as small sample sizes and biases, indicating a need for more robust research to evaluate the effectiveness of dual diagnosis training and to incorporate service user perspectives.
Dual diagnosis competencies: A systematic review of staff training literature.Petrakis, M., Robinson, R., Myers, K., et al.[2022]

References

Participants' evaluation of a training programme in dual diagnosis. [2019]
Clinical treatment matching models for dually diagnosed patients. [2005]
Dual diagnosis competencies: A systematic review of staff training literature. [2022]
Dual Diagnosis Capability in Mental Health and Substance Use Disorder Treatment Programs. [2022]
REDD-PAC Cohort Description: Researching Dual Diagnosis - Prognosis and Characteristics. [2022]
A new psychotherapy training program : description and preliminary results. [2014]
Group Training for Psychiatric Residents: Support Group Facilitation and Supervision with Didactics. [2021]
Integrating recovery-oriented practice into psychiatric registrar training. [2012]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security